Ravindra Kumar
Chief Tech/Sci/R&D Officer chez ACCELERON PHARMA INC.
Profil
Ravindra Kumar est Chief Scientific Officer & Senior Vice President chez Acceleron Pharma, Inc. Dans le passé, le Dr Kumar a occupé le poste de scientifique principal chez Genetics Institute LLC et de scientifique principal chez Wyeth Pharmaceuticals LLC. Le Dr Kumar a obtenu un doctorat de l'Université du Nouveau-Brunswick, un diplôme de deuxième cycle de l'Université Chaudhary Charan Singh et un diplôme de premier cycle de l'Université Mahatma Jyotiba Phule Rohilkhand.
Postes actifs de Ravindra Kumar
| Sociétés | Poste | Début |
|---|---|---|
| ACCELERON PHARMA INC. | Chief Tech/Sci/R&D Officer | 01/10/2012 |
| BCL INDUSTRIES LIMITED | Chief Operating Officer | - |
Anciens postes connus de Ravindra Kumar
| Sociétés | Poste | Fin |
|---|---|---|
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Corporate Officer/Principal | - |
| GLOBUS SPIRITS LIMITED | Corporate Officer/Principal | - |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formation de Ravindra Kumar
| University of New Brunswick | Doctorate Degree |
| Chaudhary Charan Singh University | Graduate Degree |
| Mahatma Jyotiba Phule Rohilkhand University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BCL INDUSTRIES LIMITED | Consumer Non-Durables |
| GLOBUS SPIRITS LIMITED | Consumer Non-Durables |
| Entreprise privées | 3 |
|---|---|
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
